Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Couillard

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Thorax|April 21, 2026
Association of blood eosinophils and exhaled nitric oxide with exacerbations in patients with asthma, COPD and asthma+COPD: the NOVELTY studySusan Muiser, Hana Müllerová, Laura Belton, et al.
BMJ Open Respiratory Research|November 28, 2025
Integrating blood eosinophils and exhaled nitric oxide (FeNO) in asthma diagnostic pathways for adults and children: the PROPULSION SANTÉ observational study with translational sub-studies (DIVE, DIVE2)-protocolsMorgane Gronnier, Laurence Désy, Lauranne Pouliot, et al.
Allergy|May 17, 2022
Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker-high and -low severe asthmaLatifa Khalfaoui, Fiona A Symon, Simon Couillard, et al.
Chest|February 1, 2026
Sex does not modify prediction of asthma attacks by clinical risk factors and Type-2 biomarkersSebastian Riemann, Fleur L Meulmeester, Samuel Mailhot-Larouche, et al.
The Lancet. Respiratory Medicine|April 11, 2025
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trialsFleur L Meulmeester, Samuel Mailhot-Larouche, Carlos Celis-Preciado, et al.
BMJ Open|March 6, 2025
The Canadian Lung Outcomes in Users of Vaping Devices (CLOUD) Study: protocol for a prospective, observational cohort studyPaloma Burns, Rachel L Eddy, Xuan Li, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2025
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Trung N Tran, Ghislaine Scelo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 28, 2025
Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World DataWenjia Chen, Trung N Tran, John Townend, et al.
The World Allergy Organization Journal|June 17, 2025
Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR)Florence Schleich, Désirée Larenas-Linnemann, Alan Altraja, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Thorax|April 21, 2026
Association of blood eosinophils and exhaled nitric oxide with exacerbations in patients with asthma, COPD and asthma+COPD: the NOVELTY studySusan Muiser, Hana Müllerová, Laura Belton, et al.
BMJ Open Respiratory Research|November 28, 2025
Integrating blood eosinophils and exhaled nitric oxide (FeNO) in asthma diagnostic pathways for adults and children: the PROPULSION SANTÉ observational study with translational sub-studies (DIVE, DIVE2)-protocolsMorgane Gronnier, Laurence Désy, Lauranne Pouliot, et al.
Allergy|May 17, 2022
Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker-high and -low severe asthmaLatifa Khalfaoui, Fiona A Symon, Simon Couillard, et al.
Chest|February 1, 2026
Sex does not modify prediction of asthma attacks by clinical risk factors and Type-2 biomarkersSebastian Riemann, Fleur L Meulmeester, Samuel Mailhot-Larouche, et al.
The Lancet. Respiratory Medicine|April 11, 2025
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trialsFleur L Meulmeester, Samuel Mailhot-Larouche, Carlos Celis-Preciado, et al.
BMJ Open|March 6, 2025
The Canadian Lung Outcomes in Users of Vaping Devices (CLOUD) Study: protocol for a prospective, observational cohort studyPaloma Burns, Rachel L Eddy, Xuan Li, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2025
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Trung N Tran, Ghislaine Scelo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 28, 2025
Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World DataWenjia Chen, Trung N Tran, John Townend, et al.
The World Allergy Organization Journal|June 17, 2025
Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR)Florence Schleich, Désirée Larenas-Linnemann, Alan Altraja, et al.
Pageof 7